Table 1.
Demographic and baseline characteristics of study patients (n = 30)
| Characteristics | |
|---|---|
| Age (yr), mean (SD) |
69.1 (13.8) |
| Male |
23 (76.7%) |
| Body mass index (kg/m2) , mean (SD) |
26.1 (4.9) |
|
Clinical history |
|
| Coronary artery disease |
29 (96.7%) |
| Hypertension |
27 (90.0%) |
| Diabetes |
23 (76.7%) |
| Stroke |
8 (26.7%) |
| Angina pectoris |
23 (76.7%) |
| Heart failure |
7 (23.3%) |
| Peripheral artery disease |
4 (13.3%) |
| Smoking status |
10 (33.3%) |
| Past smoker |
7 (70.0%) |
| Current smoker |
3 (30.0%) |
|
Previous procedures |
|
| Coronary angiography |
27 (90.0%) |
| Percutaneous coronary intervention |
12 (40.0%) |
| Coronary artery bypass grafting |
6 (20.0%) |
|
Medication |
|
| Statin |
28 (93.3%) |
| Aspirin or Clopidogrel |
27 (90.0%) |
| ACE inhibitor or ARB |
23 (76.7%) |
| Beta-blocker |
19 (63.3%) |
| Nitrate |
17 (56.7%) |
| Calcium-channel blocker (Diltiazem or Verapamil) |
10 (33.3%) |
|
Laboratory findings, mean (SD) |
|
| Hemoglobin (g/dL) |
12.9 (1.8) |
| Albumin (g/dL) |
4.2 (0.4) |
| Cholesterol (mg/dL) |
146.0 (27.0) |
| HDL cholesterol (mg/dL) |
49.5 (12.2) |
| LDL cholesterol (mg/dL) |
77.8 (19.6) |
| Triglyceride (mg/dL) |
103.3 (48.7) |
| Glucose (mg/dL) |
118.3 (27.6) |
| Hemoglobin A1C (%) |
7.5 (1.3) |
| LVEF (%) | 55.0 (17.9) |